A156T (p.Ala156Thr) variant of GLA (Alpha-galactosidase A)

A156T (p.Ala156Thr) in GLA (Alpha-galactosidase A) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic/likely pathogenic in the context of not provided; Fabry disease. The available variant effect predictions contribute to a CATVariant prioritization score of 0.79 / 1. The record also includes published literature and structural context.

A156T (p.Ala156Thr) variant details